[1] |
JIA Chengwen, JIANG Hugang, GAO Xiang, HAN Jinyan, XU Xiaodong, ZHAO Xinke.
Interventional effect of Radix Angelica Sinensis and Radix Hedysari ultrafiltration on miR-21-5P targeting TGF-β1-mediated radiation-induced myocardial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1221-1230.
|
[2] |
ZHAO Wei, WU Youyang, LIN Cong, HUANG Shiwei, CHEN Hao, JIANG Wenbing.
Effects of pterostilbene on myocardial function, myocardial fibrosis and inflammatory response in rats with acute myocardial infarction and on Notch1/eIF3a signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 498-504.
|
[3] |
ZHENG Sanfu, GUO Weixi, LUO Jinzhong, QIN Shuiqing.
Role and mechanism of platelet-derived growth factor/AKT pathway in pressure overload-induced ventricular remodeling
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 167-173.
|
[4] |
YU Ying, ZHANG Guan-jun, ZONG Qiao-feng, WANG Xiao-mei, LI Zhen-hong, GAO Qin.
Mechanism investigation of low dose ethanol intervention on myocardial fibrosis in diabetic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 379-383.
|
[5] |
LI Wen-ju, SHI Miao-qian, OU Dong-bo, DING Lu, LIU Xiao-lin, NIU Xiong-tao, ZHENG Qiang-sun.
Inhibition of fenofibrate on angiotensinⅡ-induced high expression of osteopontin in cardiac fibroblasts
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1211-1215.
|
[6] |
WANG Ai-li, CHENG Ling-ling, HU Jian-feng, CHENG Xin-yao.
Effects of atorvastatin on the proliferation and collagen synthesis of cardiac fibroblasts induced by endothelin-1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(9): 1058-1061.
|
[7] |
ZHANG Li-juan, ZHAO Lian-you, ZHENG Qiang-sun, SHANG Fu-jun, YANG Run-tao, LIU Hui, LIU Shao-wei.
Effect of simvastatin on regression of pressure overload-induced rat’ s myocardial fibrosis and its relationship with monocyte chemoattractant protein-1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(5): 521-525.
|
[8] |
BAI Yu-peng, LIU Chang hui, YANG Liu.
Effects of irbesartan on expression of connective tissue growth factor in myocardium of spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 947-952.
|
[9] |
ZHANG Ling, WANG Hong-xin.
Effects of isoproterenol on myocardial fibrosis and related cytokines in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(10): 1186-1189.
|
[10] |
WU Duo-Jiao, HONG Hua-Shan.
Progress of medication in myocardial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(12): 1327-1332.
|
[11] |
WANG Yan-Wu, XIONG Yong-Yan, CHEN Zhi-Long, LI Li.
Effects of simvastatin on myocardial fibrosis and connective tissue growth factor in renovascular hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1101-1104.
|
[12] |
LIN Wen-Hui, SONG Yu-Kang, MA Xiang-Jun.
Reverse effect of losartan on myocardial fibrosis and left ventricular hypertrophy in treatment of essential hypertensive patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(6): 539-541.
|
[13] |
YI Chun-Tao, CHENG Xiao-Shu, YU Jian-Hua, YAN Ding-Hong, SU Hai, WU Qing-Hua.
Effects of simvastatin on myocardial fibrosis in NO-deficient hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(4): 306-310.
|